(CENTA) Central Garden & Pet - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 2.163m USD | Total Return: 7% in 12m
Avg Turnover: 10.5M
EPS Trend: 29.2%
Qual. Beats: 6
Rev. Trend: -88.4%
Qual. Beats: 1
Warnings
Fakeout
Tailwinds
No distinct edge detected
Central Garden & Pet Company (CENTA) is a leading producer and distributor of branded products for the lawn, garden, and pet supplies industries in the United States. The company operates through two primary segments: Pet, featuring brands such as Nylabone and Kaytee, and Garden, which includes labels like Pennington and Amdro. Its distribution network spans big-box retailers, e-commerce platforms, and independent nurseries.
The business model relies on a dual-category approach designed to provide seasonal balance, as the garden segment peaks in spring and summer while pet supplies offer year-round recurring revenue. The household products sector is characterized by high brand loyalty, particularly in the pet health and nutrition categories where consumer spending tends to be resilient during economic cycles.
For a detailed breakdown of the companys valuation and historical performance, you may want to review the metrics on ValueRay.
- Consumer spending shifts on premium pet treats and durable supplies impact margins
- Seasonal weather patterns dictate lawn and garden segment sales volume and inventory
- Raw material cost volatility for bird seed and fertilizers affects profitability
- Retail consolidation and big-box store shelf space allocation drive revenue growth
- Strategic acquisitions and brand integration efficiency determine long-term capital allocation success
| Net Income: 171.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.64 > 1.0 |
| NWC/Revenue: 46.88% < 20% (prev 43.65%; Δ 3.22% < -1%) |
| CFO/TA 0.09 > 3% & CFO 328.3m > Net Income 171.5m |
| Net Debt (974.9m) to EBITDA (363.5m): 2.68 < 3 |
| Current Ratio: 3.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.9m) vs 12m ago -4.53% < -2% |
| Gross Margin: 32.21% > 18% (prev 0.30%; Δ 3.19k% > 0.5%) |
| Asset Turnover: 85.76% > 50% (prev 86.95%; Δ -1.18% > 0%) |
| Interest Coverage Ratio: 4.88 > 6 (EBITDA TTM 363.5m / Interest Expense TTM 57.3m) |
| A: 0.40 (Total Current Assets 2.09b - Total Current Liabilities 605.2m) / Total Assets 3.75b |
| B: 0.29 (Retained Earnings 1.09b / Total Assets 3.75b) |
| C: 0.08 (EBIT TTM 279.8m / Avg Total Assets 3.69b) |
| D: 0.52 (Book Value of Equity 1.08b / Total Liabilities 2.09b) |
| Altman-Z'' = 4.60 = AA |
| DSRI: 1.04 (Receivables 603.2m/578.9m, Revenue 3.16b/3.16b) |
| GMI: 0.93 (GM 32.21% / 30.00%) |
| AQI: 0.99 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 1.00 (Revenue 3.16b / 3.16b) |
| TATA: -0.04 (NI 171.5m - CFO 328.3m) / TA 3.75b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 34.63 with a total of 243,546 shares traded.
Over the past week, the price has changed by +0.06%,
over one month by +1.14%,
over three months by +0.00% and
over the past year by +6.95%.
Central Garden & Pet has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CENTA.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.5 | 25.6% |
P/E Trailing = 12.5709
P/E Forward = 10.6045
P/S = 0.684
P/B = 1.3096
P/EG = 1.866
Revenue TTM = 3.16b USD
EBIT TTM = 279.8m USD
EBITDA TTM = 363.5m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 51.6m USD (from shortTermDebt, last quarter)
Debt = 1.64b USD (from shortLongTermDebtTotal, last quarter) + Leases 225.9m
Net Debt = 974.9m USD (calculated: Debt 1.64b - CCE 669.4m)
Enterprise Value = 3.14b USD (2.16b + Debt 1.64b - CCE 669.4m)
Interest Coverage Ratio = 4.88 (Ebit TTM 279.8m / Interest Expense TTM 57.3m)
EV/FCF = 11.11x (Enterprise Value 3.14b / FCF TTM 282.4m)
FCF Yield = 9.00% (FCF TTM 282.4m / Enterprise Value 3.14b)
FCF Margin = 8.93% (FCF TTM 282.4m / Revenue TTM 3.16b)
Net Margin = 5.42% (Net Income TTM 171.5m / Revenue TTM 3.16b)
Gross Margin = 32.21% ((Revenue TTM 3.16b - Cost of Revenue TTM 2.14b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 30.87%)
Tobins Q-Ratio = 0.84 (Enterprise Value 3.14b / Total Assets 3.75b)
Interest Expense / Debt = 3.48% (Interest Expense 57.3m / Debt 1.64b)
Taxrate = 23.47% (24.5m / 104.5m)
NOPAT = 214.1m (EBIT 279.8m * (1 - 23.47%))
Current Ratio = 3.45 (Total Current Assets 2.09b / Total Current Liabilities 605.2m)
Debt / Equity = 1.00 (Debt 1.64b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 2.68 (Net Debt 974.9m / EBITDA 363.5m)
Debt / FCF = 3.45 (Net Debt 974.9m / FCF TTM 282.4m)
Total Stockholder Equity = 1.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 171.5m / Total Assets 3.75b)
RoE = 10.72% (Net Income TTM 171.5m / Total Stockholder Equity 1.60b)
RoCE = 10.02% (EBIT 279.8m / Capital Employed (Equity 1.60b + L.T.Debt 1.19b))
RoIC = 7.06% (NOPAT 214.1m / Invested Capital 3.03b)
WACC = 5.16% (E(2.16b)/V(3.81b) * Re(7.05%) + D(1.64b)/V(3.81b) * Rd(3.48%) * (1-Tc(0.23)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.11 | Cagr: 6.79%
[DCF] Terminal Value 73.10% ; FCFF base≈302.7m ; Y1≈265.4m ; Y5≈214.5m
[DCF] Fair Price = 48.08 (EV 3.44b - Net Debt 974.9m = Equity 2.47b / Shares 51.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 29.19 | EPS CAGR: 2.94% | SUE: 2.88 | # QB: 6
Revenue Correlation: -88.42 | Revenue CAGR: -2.47% | SUE: 2.17 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.52 | Chg30d=-4.05% | Revisions=-25% | Analysts=5
EPS current Year (2026-09-30): EPS=2.98 | Chg30d=+4.87% | Revisions=+56% | GrowthEPS=+9.0% | GrowthRev=-2.7%
EPS next Year (2027-09-30): EPS=3.10 | Chg30d=+3.52% | Revisions=+33% | GrowthEPS=+4.0% | GrowthRev=-3.2%
[Analyst] Revisions Ratio: +56%